Alka Chaubey - Sep 18, 2023 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role: Chief Medical Officer
Signature: /s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol: BNGO
Transactions as of: Sep 18, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/20/2023, 05:26 PM
Previous filing: Feb 17, 2023
Next filing: Mar 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BNGO	Common Stock	Award	$0	+20K	+16.03%	$0.00	145K	Sep 18, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BNGO	Stock Option (Right to Buy)	Award	$0	+40K		$0.00	40K	Sep 18, 2023	Common Stock	40K	$3.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
F2	The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of September 11, 2023 (the "Vesting Commencement Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Vesting Commencement Date.